Selver Işık

14PUBLICATIONS
79CO-AUTHORS
Predictive and prognostic markersMolecular targetsMedical mycologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 15, 2026
Baseline and Early On-Treatment Prognostic Nutritional Index in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer Treated with CDK4/6 Inhibitors.

|Sep 09, 2026
Real-World Efficacy and Safety of Tyrosine Kinase Inhibitors in Patients With Advanced Bone Sarcomas: The TOGBONE Study of the Turkish Oncology Group.

|Jul 15, 2026
Long-Term Outcomes and Conditional Recurrence-Free Survival in Stage II Colon Cancer: The Impact of Surveillance and Recurrence Detection Strategies.

|Mar 28, 2026
Prognostic Impact of Early Metabolic Response on Interim 18F-FDG PET/CT in HR+/HER2- Metastatic Breast Cancer Treated with CDK4/6 Inhibitors.

Vali Aliyev, Ali Kaan Güren, Murad Guliyev

|Jan 28, 2026
Prognostic Value of Systemic Immune-Inflammation Index in Mucosal Malignant Melanoma.

Burak Paçacı, Erkam Kocaaslan, Ahmet Demirel

|Jan 28, 2026
Prognostic Value of 18F-FDG PET/CT-Derived Secondary Lymphoid Organ Ratios and Hematologic Inflammation Markers in Advanced Non-Small Cell Lung Cancer Treated with Nivolumab.

Erkam Kocaaslan, Ali Kaan Güren, Fırat Akagündüz

Pageof 3

Frequent Collaborators

9 joint publications

Murat Sarı

8 joint publications

Ali Kaan Güren

8 joint publications

İbrahim Vedat Bayoğu

7 joint publications

Abdussamet Çelebi